CareStart COVID-19 Antigen Test: Rapid, Sensitive Point-of Care Test to detect Active SARS-CoV-2 Infection in 10 Minutes - EUA Authorized and CLIA-Waived for Lower Nasal Collection (640 Tests)
|
|
상품가격 상세보기
이벤트보기
|
- 상품상세정보
상품특징
Make sure this fits by entering your model number.CONVENIENT & MOBILE: All-in-one package including anterior nares (lower nasal) collection swabs. Each kit includes up to 20 antigen testsâthere is no additional training or expensive instruments needed. At any point of care (POC) environment with a CLIA certificate of waiver, the test can be administered with meaningful, easily read results in as little as 10 minutes and requires no analyzer to generate results. Each order includes 32 kits (20 tests in each kit) for a total of 640 tests.HIGH CAPACITY USA PRODUCTION: All of our EUA authorized tests are manufactured in our state-of-the-art manufacturing facility in New Jersey. With a capacity to manufacture millions of tests per month, we are ready to meet continually growing testing needs in this country.PEACE OF MIND: Helps provide critical answers about active infections to patients and healthcare workers alike, aiding in a confident return to normalcy.QUALITY YOU CAN TRUST: Highly specific (100%) and sensitive (87.2%) tests detect SARS-CoV-2 nucleocapsid protein via a lateral flow assay using lower nasal swabs. Access Bio has an 18-year track record of engineering and manufacturing superior-quality diagnostic kits for malaria, dengue, influenza, HIV and other infectious diseases.This test has been authorized by the FDA under an EUA for use by authorized laboratories and at the Point of Care (POC) by medical professionals operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation. Please view the product guide document titled "EUA Amendment" for information on the expiration extension.
상품설명
The Access Bio, Inc. CareStart COVID-19 Antigen Test is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in nasopharyngeal swab specimens directly collected from symptomatic individuals who are suspected of COVID-19 by their healthcare provider. As an intended point-of-care (POC) designated test performed by medical professionals with a 10 minutes processing time, CareStart COVID-19 Antigen Test helps provide critical answers about active infections to patients and healthcare workers alike. Please view the product guide entitled "EUA Amendment" to read about the product's expiration extension.
Make sure this fits by entering your model number.CONVENIENT & MOBILE: All-in-one package including anterior nares (lower nasal) collection swabs. Each kit includes up to 20 antigen testsâthere is no additional training or expensive instruments needed. At any point of care (POC) environment with a CLIA certificate of waiver, the test can be administered with meaningful, easily read results in as little as 10 minutes and requires no analyzer to generate results. Each order includes 32 kits (20 tests in each kit) for a total of 640 tests.HIGH CAPACITY USA PRODUCTION: All of our EUA authorized tests are manufactured in our state-of-the-art manufacturing facility in New Jersey. With a capacity to manufacture millions of tests per month, we are ready to meet continually growing testing needs in this country.PEACE OF MIND: Helps provide critical answers about active infections to patients and healthcare workers alike, aiding in a confident return to normalcy.QUALITY YOU CAN TRUST: Highly specific (100%) and sensitive (87.2%) tests detect SARS-CoV-2 nucleocapsid protein via a lateral flow assay using lower nasal swabs. Access Bio has an 18-year track record of engineering and manufacturing superior-quality diagnostic kits for malaria, dengue, influenza, HIV and other infectious diseases.This test has been authorized by the FDA under an EUA for use by authorized laboratories and at the Point of Care (POC) by medical professionals operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation. Please view the product guide document titled "EUA Amendment" for information on the expiration extension.
상품설명
The Access Bio, Inc. CareStart COVID-19 Antigen Test is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in nasopharyngeal swab specimens directly collected from symptomatic individuals who are suspected of COVID-19 by their healthcare provider. As an intended point-of-care (POC) designated test performed by medical professionals with a 10 minutes processing time, CareStart COVID-19 Antigen Test helps provide critical answers about active infections to patients and healthcare workers alike. Please view the product guide entitled "EUA Amendment" to read about the product's expiration extension.
2021-05-07 22:51:34
